Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases

Purpose Few studies have assessed the clinical features of pheochromocytoma and paraganglioma (PPGL) not producing excessive catecholamine. We aimed to clarify the clinical characteristics of PPGL patients with negative results for urinary metanephrines. Methods This is a retrospective cross-section...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2021-10, Vol.74 (1), p.155-162
Hauptverfasser: Kawashima, Akiyuki, Sone, Masakatsu, Inagaki, Nobuya, Okamoto, Kentaro, Tsuiki, Mika, Izawa, Shoichiro, Otsuki, Michio, Okamura, Shintaro, Ichijo, Takamasa, Katabami, Takuyuki, Takeda, Yoshiyu, Yoshimoto, Takanobu, Naruse, Mitsuhide, Tanabe, Akiyo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Few studies have assessed the clinical features of pheochromocytoma and paraganglioma (PPGL) not producing excessive catecholamine. We aimed to clarify the clinical characteristics of PPGL patients with negative results for urinary metanephrines. Methods This is a retrospective cross-sectional study. We established a database by combining datasets from the Nationwide Cohort Study on the Development of Diagnosis and Treatment of Pheochromocytoma in Japan (PHEO-J) and the Advancing Care and Pathogenesis of Intractable Adrenal diseases in Japan (ACPA-J). We compared the clinical differences between PPGL patients with negative results for urinary metanephrines and those with catecholamine-producing PPGL. Results Five hundred PPGL patients in the combined database were analyzed. Among them, 31 were negative for metanephrines. PPGL with negative results for urinary metanephrines was significantly associated with extra-adrenal disease (Odds ratio (OR) 6.58, 95% CI (confidence interval) 3.03–14.3, p  
ISSN:1355-008X
1559-0100
DOI:10.1007/s12020-021-02816-9